41.   Biotech companies get their big chance this week to reclaim some of the hot money that has moved into Internet stocks.

42.   Biotech companies term pipelines as the drugs they have in development and testing, before reaching the market after regulatory approval.

43.   Biotech companies would suffer the same transitional woes Genzyme had already been through.

44.   Biotech companies, grappling with low stock prices that prevent them from raising additional funds, are facing the economic downturn with their financial backs to the wall.

45.   Biotech companies also opposed legislation that would allow approval of generic versions of their drugs.

46.   Biotech companies are mining the human genome, hunting for potential drug targets, and making daily discoveries about the role of genes and proteins in disease.

47.   Biotech companies contend they are particularly vulnerable.

48.   Biotech companies did particularly well as investors looked to breakthrough medications and to the possiblity of takeovers , analysts said.

49.   Blackstone said the agreement with Biogen strengthens its early foothold in designing systems that help biotech companies handle the crush of data.

50.   Besides the classic drug-development biotech companies, others joining the ranks of public companies include diagnostics companies looking for better ways to track disease.